These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 18573829

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The natural history of primary progressive multiple sclerosis.
    Koch M, Kingwell E, Rieckmann P, Tremlett H.
    Neurology; 2009 Dec 08; 73(23):1996-2002. PubMed ID: 19996074
    [Abstract] [Full Text] [Related]

  • 3. The natural history of primary progressive MS in British Columbia, Canada.
    Tremlett H, Paty D, Devonshire V.
    Neurology; 2005 Dec 27; 65(12):1919-23. PubMed ID: 16380613
    [Abstract] [Full Text] [Related]

  • 4. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H, Yinshan Zhao, Devonshire V.
    Mult Scler; 2008 Apr 27; 14(3):314-24. PubMed ID: 18208898
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with the risk of secondary progression in multiple sclerosis.
    Koch M, Uyttenboogaart M, van Harten A, De Keyser J.
    Mult Scler; 2008 Jul 27; 14(6):799-803. PubMed ID: 18573840
    [Abstract] [Full Text] [Related]

  • 6. Does the season or month of birth influence disease progression in multiple sclerosis?
    Tremlett HL, Devonshire VA.
    Neuroepidemiology; 2006 Jul 27; 26(4):195-8. PubMed ID: 16567947
    [Abstract] [Full Text] [Related]

  • 7. Progression in familial and nonfamilial MS.
    Koch M, Uyttenboogaart M, Heerings M, Heersema D, Mostert J, De Keyser J.
    Mult Scler; 2008 Apr 27; 14(3):300-6. PubMed ID: 18208881
    [Abstract] [Full Text] [Related]

  • 8. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS.
    Neurology; 2007 Oct 09; 69(15):1498-507. PubMed ID: 17699802
    [Abstract] [Full Text] [Related]

  • 9. Cigarette smoking and progression in multiple sclerosis.
    Koch M, van Harten A, Uyttenboogaart M, De Keyser J.
    Neurology; 2007 Oct 09; 69(15):1515-20. PubMed ID: 17923613
    [Abstract] [Full Text] [Related]

  • 10. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar 09; 129(Pt 3):606-16. PubMed ID: 16415308
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K, Khader Y.
    Clin Neurol Neurosurg; 2007 Jan 09; 109(1):32-7. PubMed ID: 16870328
    [Abstract] [Full Text] [Related]

  • 12. Disability progression in multiple sclerosis is slower than previously reported.
    Tremlett H, Paty D, Devonshire V.
    Neurology; 2006 Jan 24; 66(2):172-7. PubMed ID: 16434648
    [Abstract] [Full Text] [Related]

  • 13. Relapses and progression of disability in multiple sclerosis.
    Confavreux C, Vukusic S, Moreau T, Adeleine P.
    N Engl J Med; 2000 Nov 16; 343(20):1430-8. PubMed ID: 11078767
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D, Przuntek H, Sailer M, Bethke F, Koehler J, König N, Heesen C, Späth P, Andresen I.
    Mult Scler; 2007 Nov 16; 13(9):1107-17. PubMed ID: 17623736
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
    D'hooghe MB, Haentjens P, Nagels G, Garmyn M, De Keyser J.
    Mult Scler; 2012 Apr 16; 18(4):451-9. PubMed ID: 21952096
    [Abstract] [Full Text] [Related]

  • 18. Fatigue, depression and progression in multiple sclerosis.
    Koch M, Uyttenboogaart M, van Harten A, Heerings M, De Keyser J.
    Mult Scler; 2008 Jul 16; 14(6):815-22. PubMed ID: 18535019
    [Abstract] [Full Text] [Related]

  • 19. New natural history of interferon-beta-treated relapsing multiple sclerosis.
    Trojano M, Pellegrini F, Fuiani A, Paolicelli D, Zipoli V, Zimatore GB, Di Monte E, Portaccio E, Lepore V, Livrea P, Amato MP.
    Ann Neurol; 2007 Apr 16; 61(4):300-6. PubMed ID: 17444502
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
    Glad SB, Nyland HI, Aarseth JH, Riise T, Myhr KM.
    Mult Scler; 2009 Aug 16; 15(8):942-50. PubMed ID: 19570821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.